APOMAG-62K

MILLIPLEX^® Human Apolipoprotein Magnetic Bead Panel - Cardiovascular Disease Multiplex Assay

This Bead-Based Multiplex Assay, using the Luminex^® xMAP^® technology, enables the simultaneous analysis of Apo AI, Apo AII, Apo B, Apo CII, Apo CIII, Apo E.

• 別名: human apolipoprotein CVD immunoassay panel, luminex human apolipoprotein cardiovascular disease multiplex assay, millipore human apolipoprotein CVD multiplex kit
• UNSPSCコード: 12161503
• eCl@ss: 32161000
• NACRES: NA.84

特性

• 特徴: This Bead-Based Multiplex Assay, using the Luminex^® xMAP^® technology, enables the simultaneous analysis of Apo AI, Apo AII, Apo B, Apo CII, Apo CIII, Apo E.
• 品質水準: 200
• 化学種の反応性: human
• メーカー／製品名: Milliplex^®
• assay range: accuracy: 85%; (Apo E); accuracy: 86%; (Apo AI); accuracy: 89%; (Apo CIII); accuracy: 92%; (Apo B); sensitivity: 1.00 ng/mL; (Apo AII); sensitivity: 1.22 ng/mL; (Apo CII); sensitivity: 1.42 ng/mL; (Apo E); sensitivity: 1.48 ng/mL; (Apo AI); sensitivity: 1.71 ng/mL; (Apo CIII); sensitivity: 4.84 ng/mL; (Apo B)
• テクニック: multiplexing: suitable
• 検出方法: fluorometric (Luminex xMAP)
• 輸送温度: wet ice

詳細

詳細

Metabolic Syndrome has received increased attention from the medical community with increasing cases of obesity, type 2 diabetes and related cardiovascular diseases being described and studied.

MILLIPLEX^® Human Apolipoprotein Panel is a 6-plex kit to be used for the simultaneous quantification of any or all of the following analytes in serum, plasma, tissue culture supernatant or other biological samples: APOA-1, APOA-2, APOB, APOC-2, APOC-3, and APOE. This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.

The Luminex^® xMAP^® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.

Panel Type: Cardiovascular

特異性

Cross Reactivty
To test cross-reactivity among the assays in the panel, individual apolipoprotein standard was prepared at a concentration 4 times greater than the highest concentration in the calibration curve and tested in the 6-plex assays with multiplexed beads containing immobilized capture antibodies and individual detection antibodies. There was negligible cross-reactivity within the panel.

アプリケーション

• Analytes: Apo AI, Apo AII, Apo B, Apo CII, Apo CIII, Apo E
• Recommended Sample Type: Human serum, plasma, tissue culture supernatant or other biological samples
• Recommended Sample Dilution: 10 μL of a 1: 4,000 dilution of plasma or serum
• Assay Run Time: Primary incubation of 1 hour followed by a secondary incubation of 30 minutes, both at room temperature (20-25°C)
• Research Subcategory: Cardiovascular Disease

特徴および利点

Design your multiplex kit by choosing available analytes within this panel.

その他情報

Please contact Technical Service for linearity of dilution.

Standard curve range: Refer to the kit protocol for details.

法的情報

Luminex is a registered trademark of Luminex Corp

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

xMAP is a registered trademark of Luminex Corp

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

安全性情報

• ピクトグラム: GHS05,GHS07,GHS08,GHS09
• シグナルワード: Danger
• 危険有害性情報: H302 + H312 + H332 - H317 - H318 - H373 - H411
• 注意書き: P273 - P280 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338 - P314
• 危険有害性の分類: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
• ターゲットの組織: Respiratory Tract
• 保管分類コード: 10 - Combustible liquids
• WGK: WGK 3